|

Bupropion Clinical Trials

4 actively recruiting trials across 2 locations

Also known as: ATC code: N06AX12, ATC cose: N06AX12, Wellbutrin

Pipeline

Phase 2: 1Phase 3: 2Phase 4: 1

Top Sponsors

  • Dr. Inge Winter2
  • Stony Brook University1
  • Axsome Therapeutics, Inc.1

Indications

  • Depression4
  • Major Depressive Disorder3
  • Bipolar Depression2
  • Schizophrenia and Related Disorders1
  • End Stage Kidney Disease (ESRD)1

Other2 trials

Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
Phase 3
The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Phase 3

Bellflower, California1 trial

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Clinical Research Site

Phase 4

Stony Brook, New York1 trial

Combination of Novel Therapies for CKD Comorbid Depression

Stony Brook University Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.